A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
- 30 August 2021
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 100 (5), 1132-1135
- https://doi.org/10.1016/j.kint.2021.08.017
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ TransplantsAnnals of Internal Medicine, 2021
- Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipientsAmerican Journal of Transplantation, 2021
- Occurrence of severe COVID-19 in vaccinated transplant patientsKidney International, 2021
- Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 VaccinationClinical Infectious Diseases, 2021
- Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccineKidney International, 2021